3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Glioblastoma
2
Solid Tumors
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Ovarian Neoplasms
1
Neuroectodermal Tumors
1
Nervous System Diseases
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasms
1
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
1
Head and Neck Neoplasms
1
HER2-negative Breast Cancer
1
Gliosarcoma
1
Esophageal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Paclitaxel
5
Carboplatin
3
Taxes
2
Specimen Handling
2
Nivolumab
2
Biopsy
2
rucaparib
1
rebastinib
1
pembrolizumab
1
olaparib
1
durvalumab
1
cediranib
1
capivasertib
1
cabozantinib
1
Magnetic Resonance Spectroscopy
1
LY-2157299
1
Immunoglobulin G
1
Ifosfamide
1
Fluid Therapy
1
Disulfides
1
DCC-2036
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinosarcoma
×
pamiparib
×
Clear all
No trials found.